Cullin 4 (CUL4) and small ring finger protein ROC1 assemble to form E3 ubiquitin ligase (CRL4) complexes. CUL4 interacts with WD-40 proteins through the adaptor protein DNA damage-binding protein 1 (DDB1) to target substrates for ubiquitylation. Very little is known on how the CUL4 and DDB1 interaction is regulated. Here, we show that DDB1 is acetylated and acetylation promotes DDB1 binding to CUL4. We also identify nucleolar sirtuin 7 (SIRT7) as a major deacetylase that negatively regulates DDB1-CUL4 interaction. Following inhibition of nucleolar function by actinomycin D or 5-fluorouracil treatment or knocking down the gene for the RNA polymerase I component UBF, SIRT7 is mobilized from the nucleolus to the nucleoplasm and promotes DDB1 deacetylation, leading to decreased DDB1-CUL4 association and CRL4 activity. This results in the accumulation or activation of CRL4 substrates including LATS1 and p73, which contribute to cell apoptosis induced by actinomycin D and 5-fluorouracil. Our study uncovers a novel regulation of CRL4 E3 ligase complexes.
Introduction
Sirtuins form a family of NAD + -dependent deacetylases, also categorized as the third class of histone deacetylases (HDACs) [1] . Mammalian cells have seven sirtuins (SIRT1-7) that regulate a broad range of biological processes. SIRT7, along with SIRT6, occupies an isolated branch in the phylogenetic tree of sirtuins, and its biochemical activity, molecular targets, and physiological functions are the least examined compared with other sirtuins. Only a handful of deacetylation substrates of SIRT7 have been reported so far. Different from other sirtuin members, SIRT7 is predominantly localized in the nucleolus, although a nucleoplasmic localization has also been observed [2] ). The function of SIRT7 in ribosomal biogenesis appears to be pleiotropic [3] , a notion that was supported by identification of several substrates linked with rRNA expression, including PAF53, a subunit of RNA polymerase I [2, 4] , U3-55k, a core component of the U3 small nucleolar ribonucleoprotein complex [5] . Regarding the effect of SIRT7 in various aspects of nucleolar function, it is intriguing to determine if it participates in nucleolar function inhibition-induced cell apoptosis, via modulating specific deacetylation substrates. 
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Pre-rRNA is transcribed and processed to produce ribosomal particles in the nucleolus, the nuclear subdomain formed during interphase in eukaryotic cells [6] . Nucleolar composition and morphology are affected by multiple types of stress, such as DNA damage [UV irradiation or inhibition of topoisomerase II by drugs such as etoposide and 5-flurouracil (5-FU)] [7] [8] [9] , transcriptional inhibition [by drugs such as actinomycin D (ActD)] [9, 10] , and viral infection [11] . Indeed, the nucleolus plays a central role in sensing stress and converting stress signals into cellular responses [11] . The nucleolar stress response maintains cell homeostasis, tissue integrity, and function through modulating the cell cycle, cell death, and energy-nutrient balance. A deregulated nucleolar stress response has been observed in pathogenesis of various human diseases, such as anemia [12] , cardiovascular disease [13] , and neurodegenerative disease [14] .
The CUL4-RING E3 ubiquitin ligase (CRL4) complexes consist of scaffold proteins, cullin 4A (CUL4A) and cullin 4B (CUL4B), which use a C-terminal domain to bind with the small ring finger protein regulator of cullins-1 (ROC1; also known as RBX1) and an N-terminal domain to bind with the linker protein DNA damage-binding protein 1 (DDB1), which in turn interacts with multiple DDB1-binding WD40 (DWD) /DDB1-CUL4-associated factor (DCAF) proteins to regulate the ubiquitylation of potentially a large number of substrates and a wide range of cellular processes [15, 16] . Here, we reported that DDB1, the essential adaptor of the CRL4 complex, is a novel deacetylation substrate of SIRT7. Deacetylation of DDB1 disrupts its association with CUL4A and CUL4B, and thus suppresses the activity of CRL4 complexes. We also demonstrate that under the condition of nucleolar stress induced by ActD or 5-FU, SIRT7 is released from the nucleolus into the nucleoplasm and promotes DDB1 deacetylation and CRL4 inhibition. This leads to accumulation of large tumor suppressor homolog 1 (LATS1, a major modulator of the Hippo pathway) and activation of p73, two substrates of the CRL4 E3 ligases that mediate ActD-and 5-FU-induced cell apoptosis. The way SIRT7 deacetylates DDB1 in inducing cell apoptosis upon nucleolus stress may inform the use of clinical cancer therapy drugs such as ActD and 5-FU.
Results

SIRT7 interacts with CRL4 complexes and deacetylates DDB1
As a newly defined and uniquely nucleolus localized sirtuin, SIRT7 has been less studied compared with the other sirtuins. In searching for more SIRT7-associated proteins, we performed affinity purification by mass spectrometry. Various members of the CUL4-RING/ROC1 E3 ubiquitin ligase (CRL4) complexes were identified, including DDB1, CUL4B, COP9 signalosome subunit 4, and multiple DWD (also known as DCAF) proteins (Fig. 1A) . These results are well consistent with a previous report that SIRT7 interacts with the CRL4 complex [17] . The interactions between SIRT7 and CRL4 complex members were further confirmed by coimmunoprecipitation of endogenous SIRT7-CRL4 complex (Fig. 1B,C) . Although predominantly localized in the nucleolus, SIRT7 is also observed in the nucleoplasm (Fig. 1D) [2] . Interestingly, nucleoplasmic SIRT7 showed colocalization with DDB1 ( Fig. 1D) , supporting the notion that SIRT7 interacts with the DDB1-CUL4 complex.
To address the functional significance and molecular mechanism of SIRT7-CRL4 interaction, we first tested whether SIRT7 is a substrate of CRL4 E3 ligase and 26S proteasome. By treating HEK293 cells with MG132, a proteasome inhibitor, we determined the level of SIRT7 protein and found no significant change in the steadystate level of SIRT7 over a period of 8 h (Fig. 1E) , suggesting that SIRT7 is a relatively stable protein and is not actively degraded by the proteasome pathway.
We then explored the possibility that SIRT7 may regulate the activity of the CRL4 complex. To this end, we generated HeLa and HEK293T cell lines with SIRT7 deletion using the CRISPR/Cas9 gene editing system. Successful deletion of SIRT7 was validated by western blotting (Fig. 2A,C) and Sanger sequencing ( Fig. 2B,D) . Strikingly, the acetylation of ectopically expressed DDB1 was elevated in SIRT7 KO HEK293T cells compared with the parental SIRT7 WT cells (Fig. 2E) . In contrast, CUL4A acetylation was not changed by SIRT7 deletion (Fig. 2F) , and acetylation of ectopically expressed CUL4B was barely detectable 
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Ratio (Ac/Flag) C (Fig. 2G) . Consistent with this finding, significant increase of DDB1 acetylation level was also observed in SIRT7 KO HeLa cells (Fig. 2H) . Moreover, endogenous DDB1 also exhibited a higher acetylation level in SIRT7 KO HEK293T cells when compared with the parental SIRT7 WT cells (Fig. 2I ). On the other hand, overexpression of WT, but not the catalytic mutant of SIRT7 (SIRT7 S111A ) [18] , markedly reduced the acetylation of ectopically expressed DDB1 in HEK293T cells (Fig. 2J) . To elucidate whether SIRT7 directly deacetylates DDB1, we performed an in vitro deacetylation assay using recombinant glutathione S-transferase (GST)-SIRT7 protein. The result demonstrated that incubation with GST-SIRT7 reduced the acetylation level of DDB1 in a dose-dependent manner (Fig. 2K) , indicating SIRT7 as a direct deacetylase for DDB1.
SIRT7 inhibits DDB1-CUL4 association by decreasing DDB1 acetylation
To determine the mechanistic significance of acetylation and SIRT7-catalyzed deacetylation of DDB1, we examined the effect of SIRT7 on DDB1-CUL4 association. We found that ectopic expression of WT, but not the S111A mutant of SIRT7, significantly reduced the association of CUL4A or CUL4B with ectopically expressed DDB1 (Fig. 3A) . Likewise, overexpression of SIRT7 also reduced the association of endogenous DDB1 with CUL4A or CUL4B (Fig. 3B ). In consistent with this, CUL4B-DDB1 association was increased by 40-60% in two independent SIRT7 KO HEK293T clones (Fig. 3C ). These results suggest that acetylation of DDB1 facilitates its association with both CUL4A and CUL4B and that SIRT7 may negatively regulate the function of CRL4 by deacetylating DDB1.
To further investigate the correlation between DDB1 acetylation and DDB1-CUL4B association, we performed an experiment of sequential immunoprecipitation.
Total cell extracts were firstly depleted of CUL4B by immunoprecipitation with CUL4B antibody. The resultant supernatant was then subjected to a second immunoprecipitation using a DDB1 antibody. Supernatants and immune complexes from different steps were resolved by SDS/PAGE and analyzed by immunoblotting (Fig. 3D ). When equal amount of DDB1 was loaded from the two sequential immunoprecipitations, higher acetylation level was detected in the DDB1 that was coprecipitated with CUL4B ( Fig. 3E , sample 3) than the DDB1 that was precipitated with DDB1 antibody (Fig. 3E , sample 2). Although the first immunoprecipitation with CUL4B antibody did not completely deplete the CUL4B-DDB1 complex from cell lysate, significantly less CUL4B was found in the DDB1 immunoprecipitation (Fig. 3E , sample 2) than the CUL4B immunoprecipitation (Fig. 3E , sample 3), suggesting that the majority of DDB1 in sample 2 was not in complex with CUL4B. These results show that the CUL4B-free DDB1 is hypoacetylated, supporting that DDB1 acetylation may enhance its interaction with CUL4B.
Inhibition of nucleolar function releases SIRT7 into nucleoplasm and promotes DDB1 deacetylation
Reagents that induce nucleolar stress such as ActD or 5-FU caused translocation of SIRT7 from nucleolus to nucleoplasm (Fig. 4A,B ) [2] . Considering DDB1 localization in the nucleoplasm and cytosol, these observations prompted us to examine whether DDB1 acetylation is affected by SIRT7 translocation upon nucleolar stress. Indeed, ActD treatment reduced the acetylation levels of ectopically expressed DDB1 (Fig. 4C,D) . A similar effect was observed when cells were treated with 5-FU (Fig. 4E) . In order to specifically inhibit nucleolar function, we employed siRNA to knockdown UBF (UBTF), the gene for upstream binding factor (UBF), a key RNA polymerase I-specific component involved in preinitiation complex formation and rDNA chromatin remodeling [19] . Consistent with ActD or 5-FU treatment, UBF knockdown significantly induced DDB1 deacetylation (Fig. 4F) . To decipher SIRT7's role in ActD-induced DDB1 deacetylation, we measured DDB1 acetylation level in SIRT7 KO HeLa cells upon ActD treatment. Notably, ActD failed to reduce the acetylation level of DDB1 in SIRT7 KO cells after treatment up to 2 h, compared with WT cells . HeLa cell lysates were subjected to a first immunoprecipitation with anti-CUL4B to obtain the CUL4B-associated complexes (sample 3) and remaining supernatant (sample 6). The supernatant that was depleted of CUL4B was then subjected to a second immunoprecipitation with anti-DDB1 to obtain DDB1 (sample 2). Sample 1 serves as an IgG immunoprecipitation control, while samples 4 and 5 serve as input controls. (E) CUL4B-associated DDB1 has higher acetylation level. DDB1 acetylation was detected by immunoblotting with anti-ac-lysine for samples produced by the procedure outlined in (D).
( Fig. 4G ). In addition, ActD treatment significantly induced deacetylation of endogenous DDB1 in WT cells, but not SIRT7 KO cells (Fig. 4H) . Consistently, DDB1 interaction with CUL4B was also weakened upon ActD treatment in WT cells, but not in SIRT7 KO cells (Fig. 5A) , indicating ActD regulation on CRL4 complex is mediated by SIRT7. Furthermore, we also observed an increased association between SIRT7 and CRL4 complex upon nucleolar stress induced by ActD, 5-FU treatment (Fig. 5B) or UBF knockdown (Fig. 5C ), which suggests that release of SIRT7 into the nucleoplasm increases its interaction with the CRL4 complex. Collectively, these results support a model in which SIRT7 deacetylates DDB1 and destabilizes the DDB1-CRL4 complex, while this process is significantly enhanced under the condition of nucleolar stress that releases SIRT7 to the nucleoplasm and facilitates its deacetylation of DDB1.
SIRT7 regulates stability or activity of p27, LATS1, and p73, the targets of CRL4 E3 ligases
Previous results suggest that SIRT7 may destabilize the CRL4 complex to protect CRL4 substrates from proteasome degradation. To test this hypothesis, we examined the stability of p27, which is regulated by the CRL4 E3 ubiquitin ligases. Deletion of SIRT7 reduced the protein level of p27 in both HeLa (Fig. 6A) and HEK293T (Fig. 6C ) cells without affecting p27 mRNA expression (Fig. 6B,D) . Notably, knockdown of DDB1 in SIRT7 KO cells restored p27 protein level (Fig. 6E) .
LATS1 was reported to be destabilized by poly-ubiquitylation by the CRL4 DCAF1 E3 ligase [20] . Indeed, we observed a significant reduction of LATS1 protein level in SIRT7 KO cells (Fig. 6A,C) , while its mRNA expression was not affected by SIRT7 deletion (Fig. 6B,D) . Consistently, increased poly-ubiquitylation of tagged LATS1 is observed in SIRT7 KO HEK293T cells (Fig. 6F) . LATS1 phosphorylates Yesassociation protein (YAP) at Ser127 and impairs its nuclear translocation to inhibit YAP antiapoptotic activity in the nucleus [21] [22] [23] . Consistent with the reduction of LATS1 protein level, YAP phosphorylation at Ser127 was compromised in both HeLa (Fig. 6G) and HEK293T (Fig. 6H) 
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KO cells. Taken together, these results indicate that SIRT7 regulates the steady state of p27 and LATS1 protein, likely via the CRL4 E3 ubiquitin ligases.
To test if p27 and LATS1 protein level is responsive to ActD-induced SIRT7 nucleoplasm translocation, we treated HeLa cells with ActD and found the protein levels of p27 and LATS1 were increased in a timedependent manner (Fig. 6I ). This increase, however, was not seen in SIRT7 KO HeLa cells (Fig. 6I) . The levels of p27 and LATS1 mRNA were not affected by ActD treatment in either WT or SIRT7 KO HeLa cells (Fig. 6J) . These results suggest that SIRT7 is required for ActD-induced accumulation of p27 and LATS1 protein.
In addition to poly-ubiquitylation associated with protein degradation, CRL4 E3 ligase also regulates substrates through mono-ubiquitylation. p73 is monoubiquitylated by CRL4 E3 ligase, which suppresses the trans-activation of p73 to target genes, such as puma, p21, and gadd45 [24] . Interestingly, mono-ubiquitylation of tagged p73 is significantly increased in SIRT7 KO HEK293T cells (Fig. 7A ), while its protein expression level was not affected by SIRT7 deletion (Fig. 7B,C) . In addition, ActD-or 5-FU-induced expression of p73 target genes was largely suppressed by SIRT7 deletion (Fig. 7D-G) , demonstrating SIRT7's role in promoting p73 activity.
SIRT7 promotes ActD-and 5-FU-induced cell apoptosis, possibly via LATS1 and p73
ActD and 5-FU treatment leads to cell apoptosis, at least partially through induction of nucleolar stress [8] [9] [10] . It is known that LATS1 mediates the apoptotic response through phosphorylating and inhibiting YAP activity [21, 22, 25] and also directly promoting caspase-3 activity [26] , while most target genes of p73, such as puma, p21, and gadd45 [27, 28] , are involved in cell apoptosis. These clues intrigued us and so we explored if SIRT7 has a general control of cell apoptosis in response to ActD and 5-FU.
Our results showed that ActD treatment induced cell apoptosis as determined by cell viability (Fig. 8A ), subG1 population (Fig. 8B ) and caspase-3 and poly (ADP-ribose) polymerase cleavage (Fig. 8C) , while deletion of SIRT7 significantly compromised ActDinduced cell apoptosis (Fig. 8A-C) . Furthermore, reconstitution with WT SIRT7, but not the S111A mutant, completely restored apoptotic response to ActD (Fig. 8A-C) . Similar results were observed when cell viability was measured upon 5-FU treatment (Fig. 8D) . To further address the role of LATS1 and p73 in SIRT7-mediated cell apoptosis, we knocked down lats1 and p73 in HeLa cells with SIRT7 overexpression. In accordance with previous results, overexpression of SIRT7 enhanced cell death in response to ActD treatment (Fig. 8E,F) . It is notable that knocking down of lats1 and p73 in these cells significantly restored cell viability (Fig. 8E,F) , suggesting that SIRT7-induced cell death is at least partially mediated by LATS1 and p73. Taken together, these results indicate that SIRT7 promotes ActD-and 5-FU-induced cell apoptosis, possibly via its inhibition of the DDB1-CRL4 complex and subsequently the accumulation or activation of the CRL4 substrates, LATS1 and p73. 
Discussion
Sirtuin 7 (SIRT7) was originally studied as a deacetylase targeting histones in chromatin [29] , and then more nonhistone substrates of SIRT7 were reported. In the present study, we identify DDB1 as a nonhistone target of SIRT7 deacetylation, further elaborating SIRT7 deacetylase activity. The CRL4 complex activity is n. s.
*
regulated by a variety of post-translational modifications of its components, such as CUL4-neddylation [30] . A previous study showed that SIRT7 inhibits CRL4 complex activity and leads to accumulation of TR4, a substrate of the CRL4-mediated proteasome pathway [17] . However, whether and how DDB1, CUL4 or DCAF1 proteins are directly controlled by SIRT7 remains elusive. Here, we demonstrate that SIRT7 mediates deacetylation of both ectopically expressed and endogenous DDB1 protein. DDB1 acetylation is strongly enhanced in SIRT7 KO cells (Fig. 2) , indicating that SIRT7 is a major deacetylase for DDB1. Deacetylation of DDB1 by SIRT7 disassociates it from CUL4, thus inhibiting CRL4 complex activity (Fig. 3) . To our knowledge, this is the first report of DDB1 regulation by acetylation and suggests a novel mechanism of DDB1 and CRL4 complex regulation.
To explore the consequence of SIRT7 regulation for CRL4 ligase, we detected the level or activity of several well-defined CRL4 degradation substrates. The level of p27 is controlled primarily by the ubiquitinproteasome pathway and multiple distinct E3 ubiquitin ligases have been linked to p27 ubiquitylation and degradation: SCF/CRL1-SKP2 [31] [32] [33] , and possibly multiple CRL4 E3 ligases during DNA damage response and cell differentiation [34] [35] [36] [37] [38] . Our results showed that p27 protein level is decreased by SIRT7 depletion, but increased after ActD treatment. LATS1, a major component of the Hippo pathway, is known to be regulated by the CRL4 DCAF1 E3 ligase-mediated proteasome degradation [20] . In our results, LATS1 protein level, but not mRNA level, is decreased by SIRT7 depletion, but increased after ActD treatment (Fig. 6 ). LATS1 promotes cell apoptosis by increasing caspase-3 activity and inhibiting YAP, which promotes transcription of antiapoptotic gene DIAP1 [21] [22] [23] 26, 39] . Phosphorylation of YAP Ser127 was significantly reduced in SIRT7 KO cells, indicating elevated YAP activity. Since LATS1 and YAP are critically involved in the regulation of cell apoptosis, these results support our observation of increased cell viability in SIRT7
KO cells in response to ActD-and 5-FUinduced cell apoptosis (Fig. 8) .
The p73 is a newly identified tumor suppressor encoding a protein with similar amino acid sequence to p53, acting in a p53-like manner during cell apoptosis through stimulating transcription of pro-apoptotic genes such as puma, p21, and gadd45 [27, 28] . Such activity of p73 is suppressed by CRL4-mediated mono-ubiquitylation [24] . In our results, p73 monoubiquitylation was significantly increased by SIRT7 deletion (Fig. 7) . Additionally, ActD-or 5-FU-induced expression of p73 target genes was largely compromised in SIRT7 KO cells (Fig. 7) . This may provide another explanation for cell resistance to apoptosis with SIRT7 knockout. In summary, both the LATS1 accumulation and p73 activation may contribute to cell apoptosis induced by ActD and 5-FU. Due to the diversity of substrates regulated by the CRL4 E3 ligases, we do not rule out that additional CRL4 substrates are regulated by SIRT7 and involved in ActDor 5-FU-induced cell apoptosis.
Collectively, our work demonstrates a novel role of SIRT7 in the regulation of the CRL4 E3 ligase activity through deacetylating DDB1, a process that is exploited in nucleolar stress-induced cell apoptosis. Certain nucleolar function effectors, such as p27, LATS1, and p73, are among the CRL4 substrates that are regulated by SIRT7. The nucleolus has emerged as a central hub for coordinating cellular stress responses [11] . We propose that release of SIRT7 from nucleolus to nucleoplasm may be an important step in mediating stress-induced cell apoptosis, possibly by altering CRL4 control on LATS1 and p73 (Fig. 9) . The 
Materials and methods
Antibodies
Antibodies specific for the following were purchased com- 
Plasmids and chemicals
The cDNA encoding full-length human SIRT7, DDB1, CUL4B, and CUL4A were cloned into Flag-, HA-, or MYC-tagged vectors (pcDNA-Flag; pcDNA-HA and pcDNA-MYC). Point mutation of SIRT7 was generated by QuickChange Site-Directed Mutagenesis kit (Agilent, Santa Clara, CA, USA). MG132 (C2211, Sigma-Aldrich) was used to inhibit the proteasome. Actinomycin D (Sigma-Aldrich, cat. no. A1410) and 5-fluorouracil (Sigma-Aldrich, cat. no. F6627-1G) were used to induce cell apoptosis.
Cell culture, transfection, and treatment
Both HEK293T cells and HeLa were cultured in Dulbecco's modified Eagle's medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 5% fetal bovine serum (Thermo Fisher Scientific) and antibiotics (100 unitsÁmL À1 penicillin and 100 lgÁmL À1 streptomycin), in a 5%
CO 2 atmosphere at 37°C. Plasmid transfection was carried out using the polyethyleneimene (Sigma-Aldrich). 
Immunoprecipitation and western blotting
HPLC-tandem mass spectrometry analysis
The tryptic peptides of protein samples were dissolved in Solvent A (0.1% formic acid, 2% acetonitrile in water) and loaded onto an in-house packed capillary column (75 lm ID 9 15 cm) with C 18 reverse-phase resin (3 lm, 100 A, Dikma Technologies Inc., Lake Forest, CA, USA) connected to an EASY-nLC 1000 HPLC system (Thermo Fisher Scientific). The peptides were then eluted with a 62 min gradient from 5% to 45% of Solvent B (0.1% formic acid in acetonitrile) at the flow rate of 300 nLÁmin 
Immunofluorescence staining
HeLa cells were cultured on fibronectin-coated coverslips to the appropriate density and treated as indicated in specific experiments. Cells were fixed with 4% paraformaldehyde 
Cell survival assay
WT, SIRT7 KO , SIRT7 KO with reconstitution of WT SIRT7
or SIRT7-S111A HeLa cells were seeded in six-well plates at a density of 4 9 10 5 cells per well. After incubation with 100 lM 5-FU (Sigma-Aldrich) for 36 and 60 h, or 40 nM ActD for 4 h followed by 36 and 48 h recovery, the remaining live cells were trypsinized, dyed by trypan blue as protocol and counted with a Countstar IC1000 (Shanghai, China).
Generation of SIRT7 knockout cells using the CRISPR/Cas9 genome editing system
Generation of knockout cells was described elsewhere [40] , and the protocol was followed for the generation of SIRT7 knockout HEK293T and HeLa cells. The 20-nucleotide (nt) guide sequence targeting exon 1 of the human Sirt7 gene was 5 0 -CCGCTCCGAGCGCAAAGCGG-3 0 . Guide sequences were cloned into a bicistronic expression vector (pX459) containing human codon-optimized Cas9 and the RNA components. HEK293T and HeLa cell lines with Sirt7 knockout were screened and verified by both western blotting for whole-cell lysate and Sanger sequencing of genomic DNA.
RNA interference
RNAi-mediated down-regulation of human UBF was performed by transfecting siRNA oligonucleotides (siRNAs) into HeLa cells in accordance with the manufacturer's instructions using Lipofectamine RNAi MAX (Thermo Fisher Scientific). A nontargeting control siRNA duplex (sense 5 0 -UUCUCCGAACGUGUCACGUTT-3 0 ) was included as a negative control. The knockdown efficiency was assessed 72 h after transfection by western blot.
The siRNAs targeting UBF were designed by the Thermo Fisher Scientific online tool and synthesized by Genepharma Inc. The sequences of all siRNAs used in this study are shown below: si UBF 1: CCACGAGAAGAAGGTGTAT si UBF 2: GGAGGATGATGAAGAGGAT si LATS1: CACGGCAAGATAGCATGGATT si p73: GGGCCATGCCTGTTTACAA
RNA isolation and quantitative real-time PCR analysis
Total RNA was isolated from cultured cells using Trizol reagent (Thermo Fisher Scientific) following the manufacturer's instructions. Total RNA (2-5 lg) was reversely transcribed with oligo-dT primers and preceded in qRT-PCR by gene-specific primers in the presence of SYBR Premix Ex Taq (TaKaRa, Dalian, China). All samples were run in triplicate and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an endogenous control. Relative abundance of mRNA was determined on a 7500 realtime PCR system (Thermo Fisher Scientific). Fold changes of RNA levels were calculated using the DDC t method and analyzed by Student's t test. Primer sequences (5 0 -3 0 ) were as followed, 
In vitro deacetylation assay
In vitro deacetylation was performed as described before [41] . GST-tagged SIRT7 construct was provided by Dr D. Gao (Shanghai Institutes for Biochemistry and Cell Biology, Shanghai) and recombinant GST-SIRT7 was expressed and purified from E. coli. To perform the in vitro deacetylation assay, DDB1-Flag expressed and purified from HeLa cells was incubated with a gradient dose of recombinant GST-SIRT7 in 30 lL of deacetylation reaction buffer [50 mM Tris/HCl (pH 9.0), 1 mM MgCl 2 , 50 mM NaCl, and 0.5 mM dithiothreitol (DTT)], with or without 1.5 mM nicotinamide adenine dinucleotide (NAD) at 37°C for 2 h. The reactions were stopped by adding SDS/PAGE sample buffer and resolved for western blotting to detect the acetylation level of DDB1.
Statistical analysis
Statistical analyses were performed with Student's twotailed unpaired t test. All data shown represent the results obtained from triplicated independent experiments with standard deviation of the mean (mean AE SD). The values of P < 0.05 were considered statistically significant.
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